UNKNOWN PRIMARY TUMORS
Clinical trials for UNKNOWN PRIMARY TUMORS explained in plain language.
Never miss a new study
Get alerted when new UNKNOWN PRIMARY TUMORS trials appear
Sign up with your email to follow new studies for UNKNOWN PRIMARY TUMORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
DNA-Guided immunotherapy trial aims to match drug to tumor
Disease control Recruiting nowThis study tests the immunotherapy drug atezolizumab in 200 people with advanced solid tumors (breast, lung, GI, and others). Researchers use each person's tumor DNA to see if it predicts a response. Participants get the same dose every 3 weeks. The goal is to see if DNA analysis…
Matched conditions: UNKNOWN PRIMARY TUMORS
Phase: PHASE2 • Sponsor: British Columbia Cancer Agency • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
DNA fingerprinting could solve the mystery of unknown primary cancers
Diagnosis Recruiting nowThis study is testing a new tool that uses DNA methylation patterns to figure out where a cancer started when doctors can't find the original tumor. Researchers will analyze tissue samples from 120 people with cancer of unknown primary. If it works, this could help guide more per…
Matched conditions: UNKNOWN PRIMARY TUMORS
Sponsor: Sun Yat-sen University • Aim: Diagnosis
Last updated Jun 27, 2026 12:23 UTC
-
Massive cancer DNA hunt aims to stop relapse before it starts
Knowledge-focused Recruiting nowThis study enrolls 7,000 people with various cancers who have had or will have treatment aimed at a cure. Researchers collect blood, tissue, urine, and saliva samples over time to look for tiny bits of cancer DNA left behind. The goal is to find any remaining cancer as early as p…
Matched conditions: UNKNOWN PRIMARY TUMORS
Sponsor: University Health Network, Toronto • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:31 UTC